IL125848A - Pharmaceutical compositions containing clopidogrel and aspirin and their use for the preparation of a medicine for the treatment of a pathology induced by platelet aggregation - Google Patents

Pharmaceutical compositions containing clopidogrel and aspirin and their use for the preparation of a medicine for the treatment of a pathology induced by platelet aggregation

Info

Publication number
IL125848A
IL125848A IL12584897A IL12584897A IL125848A IL 125848 A IL125848 A IL 125848A IL 12584897 A IL12584897 A IL 12584897A IL 12584897 A IL12584897 A IL 12584897A IL 125848 A IL125848 A IL 125848A
Authority
IL
Israel
Prior art keywords
aspirin
medicine
preparation
treatment
pharmaceutical compositions
Prior art date
Application number
IL12584897A
Other languages
English (en)
Other versions
IL125848A0 (en
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9489354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL125848(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of IL125848A0 publication Critical patent/IL125848A0/xx
Publication of IL125848A publication Critical patent/IL125848A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Medical Uses (AREA)
IL12584897A 1996-02-19 1997-02-17 Pharmaceutical compositions containing clopidogrel and aspirin and their use for the preparation of a medicine for the treatment of a pathology induced by platelet aggregation IL125848A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602027A FR2744918B1 (fr) 1996-02-19 1996-02-19 Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
PCT/FR1997/000296 WO1997029753A1 (fr) 1996-02-19 1997-02-17 Nouvelles associations de principes actifs contenant du clopidogrel et un antithrombotique

Publications (2)

Publication Number Publication Date
IL125848A0 IL125848A0 (en) 1999-04-11
IL125848A true IL125848A (en) 2000-11-21

Family

ID=9489354

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12584897A IL125848A (en) 1996-02-19 1997-02-17 Pharmaceutical compositions containing clopidogrel and aspirin and their use for the preparation of a medicine for the treatment of a pathology induced by platelet aggregation

Country Status (29)

Country Link
US (1) US5989578A (de)
EP (1) EP0881901B1 (de)
JP (1) JP3662028B2 (de)
KR (1) KR100295345B1 (de)
CN (1) CN1116042C (de)
AT (1) ATE218870T1 (de)
AU (1) AU715655B2 (de)
BR (1) BR9707556A (de)
CA (1) CA2246289C (de)
CZ (1) CZ292363B6 (de)
DE (2) DE122010000030I2 (de)
DK (1) DK0881901T3 (de)
EE (1) EE03513B1 (de)
ES (1) ES2176684T3 (de)
FR (1) FR2744918B1 (de)
HK (1) HK1017850A1 (de)
HU (1) HU225036B1 (de)
IL (1) IL125848A (de)
IS (1) IS1892B (de)
NO (2) NO317747B3 (de)
NZ (1) NZ331444A (de)
PL (1) PL187292B1 (de)
PT (1) PT881901E (de)
RU (1) RU2184547C2 (de)
SI (1) SI0881901T1 (de)
SK (1) SK284285B6 (de)
TR (1) TR199801608T2 (de)
UA (1) UA51695C2 (de)
WO (1) WO1997029753A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1061908A4 (de) * 1998-03-13 2007-01-24 Merck & Co Inc Kombinationstherapie und zusammenstellung für akutes koronarischämiesyndrom und damit zusammenhängende zustände
WO1999065500A1 (en) 1998-06-17 1999-12-23 Bristol-Myers Squibb Company Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
US6509348B1 (en) 1998-11-03 2003-01-21 Bristol-Myers Squibb Company Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
FR2792836B3 (fr) 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
CZ297570B6 (cs) * 2000-12-25 2007-02-07 Sankyo Company, Limited Farmaceutický prípravek obsahující 2-acetoxypyridinový derivát a aspirin, které spolu pusobí v synergickém úcinku, kit jej obsahující a pouzití
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
FR2832929A1 (fr) * 2001-12-05 2003-06-06 Sanofi Synthelabo Compositions pharmaceutiques contenant un agent antithrombotique et un derive d'amines cycliques
WO2004031143A2 (en) * 2002-10-02 2004-04-15 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
ES2378544T3 (es) 2003-07-08 2012-04-13 Accumetrics, Inc. Activación selectiva de plaquetas para el seguimiento de terapia con antagonistas de ADP
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
HUP0400982A2 (en) * 2004-05-17 2006-08-28 Chemor Kutato New veterinary product for honeybees
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
CN101253179B (zh) * 2005-09-21 2010-12-29 株式会社钟根堂 S-氯吡格雷的树脂酸盐复合物及其制备方法
WO2008048083A1 (es) * 2006-10-17 2008-04-24 Espinosa Abdala Leopoldo De Je Composiciones farmacéuticas para el tratamiento de enfermedades tromboembólicas
DE102006051625A1 (de) 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
MX2009011619A (es) 2007-04-27 2010-01-18 Cydex Pharmaceuticals Inc Formulaciones que contienen clopidogrel y eter sulfoalquilico-ciclodextrina y metodos de uso.
WO2009104932A2 (ko) * 2008-02-22 2009-08-27 한올제약주식회사 복합제제
DE102008032361A1 (de) 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
WO2010132711A1 (en) 2009-05-13 2010-11-18 Cydex Pharmaceuticals, Inc. Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
WO2010151095A1 (en) 2009-06-25 2010-12-29 Tetra, Sia Novel acetylsalicylic acid salts
WO2011071853A2 (en) 2009-12-07 2011-06-16 Academic Pharmaceuticals Incorporated Parenteral formulation of clopidogrel
CN102389436A (zh) * 2011-09-09 2012-03-28 北京阜康仁生物制药科技有限公司 一种抗血小板聚集的药物组合物
KR101675501B1 (ko) * 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
US8513278B2 (en) 2011-11-26 2013-08-20 Academic Pharmaceuticals, Inc. Parenteral dextrose formulation of clopidogrel
CN102406938A (zh) * 2011-11-29 2012-04-11 北京阜康仁生物制药科技有限公司 一种抗血栓的药物组合物
KR101473268B1 (ko) * 2012-03-09 2014-12-16 주식회사유한양행 클로피도그렐과 아스피린을 포함하는 약학 조성물 및 그의 제조방법
CN103720700A (zh) * 2012-10-10 2014-04-16 江苏威凯尔医药科技有限公司 含有阿斯匹林和维卡格雷的药用组合物
DK2796145T3 (da) 2013-04-22 2018-01-29 Csl Ltd Et kovalent kompleks af von Willebrand-faktor og faktor VIII linket af en disulfidbro
KR101502588B1 (ko) 2013-05-01 2015-03-16 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
JP5905165B2 (ja) * 2013-08-02 2016-04-20 サノフイ アセチルサリチル酸およびクロピドグレルを含む医薬錠剤
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN107698620A (zh) * 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
RU2745774C1 (ru) * 2020-08-14 2021-03-31 Алексей Викторович Марочков Способ лечения пациентов с новой коронавирусной инфекцией (covid-19)
US20230059869A1 (en) 2021-08-03 2023-02-23 Liqmeds Worldwide Limited Oral pharmaceutical solution of clopidogrel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire

Also Published As

Publication number Publication date
FR2744918B1 (fr) 1998-05-07
NO317747B3 (no) 2011-10-03
NZ331444A (en) 2001-04-27
EE9800247A (et) 1999-02-15
DE69713287D1 (de) 2002-07-18
RU2184547C2 (ru) 2002-07-10
IS1892B (is) 2003-10-20
ATE218870T1 (de) 2002-06-15
IL125848A0 (en) 1999-04-11
PL187292B1 (pl) 2004-06-30
HUP9901144A3 (en) 2001-04-28
HU225036B1 (en) 2006-05-29
CN1116042C (zh) 2003-07-30
EP0881901A1 (de) 1998-12-09
SI0881901T1 (en) 2002-10-31
FR2744918A1 (fr) 1997-08-22
HUP9901144A2 (hu) 1999-09-28
JP3662028B2 (ja) 2005-06-22
UA51695C2 (uk) 2002-12-16
SK284285B6 (sk) 2005-01-03
BR9707556A (pt) 1999-07-27
TR199801608T2 (xx) 1998-11-23
JPH11510818A (ja) 1999-09-21
NO317747B1 (no) 2004-12-13
DE122010000030I1 (de) 2010-10-21
NO983812L (no) 1998-10-09
PL327923A1 (en) 1999-01-04
SK110598A3 (en) 1999-01-11
CZ249998A3 (cs) 1998-11-11
NO983812D0 (no) 1998-08-19
US5989578A (en) 1999-11-23
CA2246289C (fr) 2003-12-16
DK0881901T3 (da) 2002-10-07
WO1997029753A1 (fr) 1997-08-21
HK1017850A1 (en) 1999-12-03
NO2010015I1 (no) 2010-07-26
NO2010015I2 (no) 2012-11-12
CZ292363B6 (cs) 2003-09-17
CN1211922A (zh) 1999-03-24
KR19990087163A (ko) 1999-12-15
DE122010000030I2 (de) 2012-06-21
EP0881901B1 (de) 2002-06-12
DE69713287T2 (de) 2002-12-19
ES2176684T3 (es) 2002-12-01
KR100295345B1 (ko) 2001-08-07
IS4827A (is) 1998-08-18
AU715655B2 (en) 2000-02-10
PT881901E (pt) 2002-09-30
AU1884497A (en) 1997-09-02
EE03513B1 (et) 2001-10-15
CA2246289A1 (fr) 1997-08-21

Similar Documents

Publication Publication Date Title
IL125848A (en) Pharmaceutical compositions containing clopidogrel and aspirin and their use for the preparation of a medicine for the treatment of a pathology induced by platelet aggregation
PL312441A1 (en) New pharmaceutical compositions
DE69502939D1 (de) Sublinguales oder bukkales arzneimittel
CA2293823A1 (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
BR9406893A (pt) Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids
PL326149A1 (en) Pharmaceutic dipeptides containing angiostatic agents and methods of their application
IL108234A0 (en) Pharmaceutical composition containing galanthamine
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
MY124465A (en) Reduction of infarct volume using citicoline
IL102032A0 (en) 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
GEP20043377B (en) Pharmaceutical Complex
FR2710844B1 (fr) Composition pour le traitement ou la prévention de l'herpès.
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
ITMI931598A1 (it) Uso terapeutico della fosfocreatina
JO1750B1 (en) Substituted benzimidazole compounds, practical to prepare and use

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired